• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Authors


Mylissa Price, MPH, RPh

Latest:

Evaluating Proactive Outreach for Prior Authorization Recertifications in Medicaid Patients

Implementing a proactive provider outreach program resulted in significantly more prior authorization recertifications and a reduction in time to submission.



Antonio J. Trujillo, PhD

Latest:

The Price Paradox of Biosimilar-Like Long-Acting Insulin

Findings suggest that Basaglar was not less expensive for patients than Lantus. Empirical evaluation of biosimilar costs prior to automatic substitution is necessary.


Janet Childerhose, PhD

Latest:

Integrating Primary Care and Public Health for Advance Care Planning

This article proposes a new model, Public-Primary ACP, that leverages coordination between primary care and public health workforces to improve delivery of advance care planning.


Delphine Tuot, MD

Latest:

Implementing Team-Based Telemedicine Workflows in Safety-Net Primary Care

Telemedicine in safety-net primary care faces particular challenges. Consistent, team-based workflows can support video visit implementation and health care maintenance in telemedicine visits.


Karen Alexander, PhD, RN

Latest:

Contingency Management: Promises, Gaps, and Philosophical Limitations

This editorial reviews the promises, gaps, and philosophical limitations of contingency management for pregnant people who use drugs.


Kristen D. Krause, PhD, MPH

Latest:

Contributor: Reflections on World AIDS Day 2023—A Call to Increase Research Funding on HIV and Aging

Research on HIV and aging should be the focus of future research as World AIDS Day brings the chronic illness to the forefront.


Karen Winkfield, MD, PhD | Image Credit: © Vanderbilt University Medical Center
Karen Winkfield, MD, PhD

Latest:

Expanding Access to Clinical Trials Through Community Partnerships

Karen Winkfield, MD, PhD, addresses the importance of meeting patients where they are to expand clinical trial participation and remove barriers to trial access.


Jozefine C. Verloop, MD

Latest:

Identifying Complex Patients Using Adjusted Clinical Groups Risk Stratification Tool

In this study, the authors developed a method for use in primary care to identify a group of patients with complex care needs using Aggregated Diagnosis Groups.


Abigail Eaton, PhD

Latest:

Opioid Safety Initiative Associated With Decreased Emergency Department Opioid Prescribing

A scalable health system–wide emergency physician education and feedback initiative was associated with decreased opioid prescribing, in excess of background temporal decline.


Barry Goy, MD

Latest:

Receiving NADT for 6 Months Doesn’t Impact Outcomes in Intermediate-Risk Prostate Cancer After EBRT

Adding 6 months of neoadjuvant deprivation therapy (NADT) doesn’t seem to add any benefit for patients with intermediate-risk prostate cancer treated with external-beam radiation therapy (EBRT), according to 15-year outcomes presented by Barry Goy, MD, of Kaiser Permanente.


Yu-Hsiang Meng, MD

Latest:

Association Between Screening for Suspected COVID-19 Cases and Outcomes of Patients Revisiting the Emergency Department

Patients who revisit the emergency department shortly after discharge are at high risk for complications and death, exacerbated by COVID-19 screening workload. Detection efforts impact outcomes.


Jane M. Zhu, MD, MPP, MSHP

Latest:

Persistence of Provider Directory Inaccuracies After the No Surprises Act

Relying on a 2-stage secret shopper survey, the authors found that inaccuracies in provider directories often persisted for well over 1 year.


Charles T. Pu, MD

Latest:

The Essential Role of Population Health During and Beyond COVID-19

The authors detail how population health management enables health systems to promote public health, strengthen health system resiliency, and support financial recovery during and beyond coronavirus disease 2019 (COVID-19).


Ariel Caplan, BS

Latest:

Post-SNF Outcomes and Cost Comparison: Medicare Advantage vs Traditional Medicare

Patients enrolled in Medicare Advantage had better outcomes and lower cost following skilled nursing facility (SNF) discharge than patients enrolled in traditional fee-for-service Medicare.


Gary E. Bisbee, PhD, MBA

Latest:

Contributor: 3 Key Questions for the Biden Administration and the 117th Congress Coming Out of the COVID-19 Crisis

The incoming Biden administration will be challenged to address flex capacity, the supply chain, and real-time data as we transition from coronavirus disease 2019 (COVID-19) response to durable recovery.


Insiya B. Poonawalla, PhD, MS

Latest:

Medication Adherence Star Ratings Measures, Health Care Resource Utilization, and Cost

For patients prescribed diabetes, hypertension, and hyperlipidemia medications, nonadherence to CMS Star Ratings quality measures of medication adherence was associated with increased health care resource utilization and costs.


Marian J. Gilmore, MS, CGC

Latest:

Impact of Expanded Carrier Screening on Health Care Utilization

This study shows little evidence of harms or increased health care utilization for people receiving negative (normal) results of expanded carrier screening through genome sequencing.


Jie Liu, MD, MPH

Latest:

Responsibility for Treating Tobacco Dependence in Health Clinics Serving Medicaid Enrollees

This article describes the implementation of Medicaid smoking cessation guidance in a large, urban federally qualified health center to examine how state-level provisions translated into clinic-level policies.


Joseph Simonetti, MD, MPH

Latest:

Cost Savings Associated With Electronic Specialty Consultations

This retrospective cohort evaluation found that patients receiving electronic, compared with face-to-face, specialty consultation had significantly lower health care costs for at least 3 months.


Robert Toto, MD

Latest:

Changing Practice Patterns in CKD

Closing out the discussion, an expert in chronic kidney disease (CKD) highlights how care for patients with CKD may change in the future based on data presented at AMCP.


Cliff Molife, PhD

Latest:

Treatment Patterns for Patients With Advanced/Metastatic Cancers by Site of Care

Treatment patterns and overall survival were similar regardless of site of care between patients receiving anticancer therapy in the hospital outpatient vs physician office setting.


Jill Glassman, PhD, MSW

Latest:

An Evaluation of a Care Coaching and Provider Referral Intervention for Behavioral Health Needs

Care coaching and behavioral health provider referral programs produce long-term savings, reductions in avoidable utilization, and increases in targeted services to treat behavioral health conditions.


Rebecca L. Attridge, PharmD, MSc, BCPS, BCCCP

Latest:

Rituximab Reference vs Biosimilar Utilization for Oncology vs Nononcology Indications

Reporting on the real-world utilization of reference rituximab and its biosimilars can help show prescribing habits and reveal cost-saving opportunities.


Bhav Jain, BS

Latest:

Value Realization: An Unattained Challenge for Integrated Practice Units

As value realization eludes integrated practice units (IPUs), the authors examine 6 key value drivers for IPU teams to competitively drive volumes and hone their multidisciplinary competencies.


Danny Rischin, MD

Latest:

Why ASCO Is a Must-Attend Event for Oncologists Worldwide

Leaders in oncology share why the American Society of Clinical Oncology (ASCO) meeting remains a top global gathering for breakthroughs, networking, and lifelong learning.


Michael Thomsen, PhD

Latest:

Predictive Models for Low Birth Weight: A Comparative Analysis of Algorithmic Fairness–Improving Approaches

This study compared 6 algorithmic fairness–improving approaches for low-birth-weight predictive models and found that they improved accuracy but decreased sensitivity for Black populations.


Heidi S. Wirtz, PharmD, PhD

Latest:

Health Care Resource Utilization, Quality Metrics, and Costs of Bladder Cancer Within the Oncology Care Model

Spending on novel therapies in high-risk bladder cancer had minimal impact on Oncology Care Model payments to practices, according to this cohort study and an average performance estimation.


Eliza Kruger, MHEcon

Latest:

US Cost-effectiveness and Budget Impact of Point-of-Care NAAT for Streptococcus

This study evaluates the cost-effectiveness and budget impact to US payers of point-of-care nucleic acid amplification tests (NAAT) for group A streptococcus.


Eugean Jiwanmall, MPH, MBA

Latest:

Comprehensive Genomic Profiling in Community Oncology

Recommendations to address limitations in more widespread use of reflex testing in community oncology.

© 2025 MJH Life Sciences
AJMC®
All rights reserved.